Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Bayesian nonparametric comorbidity analysis of psychiatric disorders

  • Rodríguez Ruiz, Francisco Jesús
  • Valera Martínez, María Isabel
  • Blanco, Carlos
  • Pérez Cruz, Fernando
The analysis of comorbidity is an open and complex research Field in the branch of psychiatry, where clinical experience and several studies suggest that the relation among the psychiatric disorders may have etiological and treatment implications. In this paper, we are interested in applying latent feature modeling to Find the latent structure behind the psychiatric disorders that can help to examine and explain the relationships among them. To this end, we use the large amount of information collected in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) database and propose to model these data using a nonparametric latent model based on the Indian BuFiet Process (IBP). Due to the discrete nature of the data, we First need to adapt the observation model for discrete random variables. We propose a generative model in which the observations are drawn from a multinomial-logit distribution given the IBP matrix. The implementation of an eFicient Gibbs sampler is accomplished using the Laplace approximation, which allows integrating out the weighting factors of the multinomial-logit likelihood model. We also provide a variational inference algorithm for this model, which provides a complementary (and less expensive in terms of computational complexity) alternative to the Gibbs sampler allowing us to deal with a larger number of data. Finally, we use the model to analyze comorbidity among the psychiatric disorders diagnosed by experts from the NESARC database., Francisco J. R. Ruiz is supported by an FPU fellowship from the Spanish Ministry of Education (AP2010-5333), Isabel Valera is supported by the Plan Regional-Programas I+D of Comunidad de Madrid (AGES-CM S2010/BMD-2422), Fernando P erez-Cruz has been partially supported by a Salvador de Madariaga grant, and Carlos Blanco acknowledges NIH grants (DA019606 and DA023200) and the New York State Psychiatric Institute for their support. The authors also acknowledge the support of Ministerio de Ciencia e Innovación of Spain (projects DEIPRO TEC2009-14504-C02-00, ALCIT TEC2012-38800-C03-01, and program Consolider-Ingenio 2010 CSD2008-00010 COMONSENS). This work was also supported by the European Union 7th Framework Programme through the Marie Curie Initial Training Network \Machine Learning for Personalized Medicine" MLPM2012, Grant No. 316861.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Bayesian Nonparametric Crowdsourcing

  • García Moreno, Pablo
  • Artés Rodríguez, Antonio
  • Teh, Yee Whye
  • Pérez Cruz, Fernando
Crowdsourcing has been proven to be an effective and efficient tool to annotate large data-sets. User annotations are often noisy, so methods to combine the annotations to produce reliable estimates of the ground truth are necessary. We claim that considering the existence of clusters of users in this combination step can improve the performance. This is especially important in early stages of crowdsourcing implementations, where the number of annotations is low. At this stage there is not enough information to accurately estimate the bias introduced by each annotator separately, so we have to resort to models that consider the statistical links among them. In addition, finding these clusters is interesting in itself as knowing the behavior of the pool of annotators allows implementing efficient active learning strategies. Based on this, we propose in this paper two new fully unsupervised models based on a Chinese restaurant process (CRP) prior and a hierarchical structure that allows inferring these groups jointly with the ground truth and the properties of the users. Efficient inference algorithms based on Gibbs sampling with auxiliary variables are proposed. Finally, we perform experiments, both on synthetic and real databases, to show the advantages of our models over state-of-the-art algorithms., Pablo G. Moreno is supported by an FPU fellowship from the Spanish Ministry of Education (AP2009-1513). This work has been partly supported by Ministerio de Economía of Spain (’COMONSENS’, id. CSD2008-00010, ’ALCIT’, id. TEC2012-38800-C03-01, ’COMPREHENSION’, id. TEC2012-38883-C02-01) and Comunidad de Madrid (project ’CASI-CAM-CM’, id. S2013/ICE-2845). This work was also supported by the European Union 7th Framework Programme through the Marie Curie Initial Training Network ”Machine Learning for Personalized Medicine” MLPM2012, Grant No. 316861. Yee Why Teh’s research leading to these results has received funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013) ERC grant agreement no. 617411.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Prior Design for Dependent Dirichlet Processes: An Application to Marathon Modeling

  • Fernández Pradier, Mélanie
  • Rodríguez Ruiz, Francisco Jesús
  • Pérez Cruz, Fernando
This paper presents a novel application of Bayesian nonparametrics (BNP) for marathon data modeling. We make use of two well-known BNP priors, the single-p dependent Dirichlet process and the hierarchical Dirichlet process, in order to address two different problems. First, we study the impact of age, gender and environment on the runners' performance. We derive a fair grading method that allows direct comparison of runners regardless of their age and gender. Unlike current grading systems, our approach is based not only on top world records, but on the performances of all runners. The presented methodology for comparison of densities can be adopted in many other applications straightforwardly, providing an interesting perspective to build dependent Dirichlet processes. Second, we analyze the running patterns of the marathoners in time, obtaining information that can be valuable for training purposes. We also show that these running patterns can be used to predict finishing time given intermediate interval measurements. We apply our models to New York City, Boston and London marathons., M. F. Pradier is supported by the European Union 7th Framework Programme through the Marie Curie Initial Training Network “Machine Learning for Personalized Medicine” MLPM2012, Grant No. 316861. F. J. R. Ruiz is supported by an FPU fellowship from the Spanish Ministry of Education (AP2010-5333). This work is also partially supported by Ministerio de Economía of Spain (projects COMPREHENSION, id. TEC2012-38883-C02-01, and ALCIT, id. TEC2012-38800-C03-01), by Comunidad de Madrid (project CASI-CAM-CM, id. S2013/ICE-2845), and by the Office of Naval Research (ONR N00014-11-1-0651).
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Entropy-constrained scalar quantization with a lossy-compressed bit

  • Fernández Pradier, Mélanie
  • Martínez Olmos, Pablo
  • Pérez Cruz, Fernando
We consider the compression of a continuous real-valued source X using scalar quantizers and average squared error distortion D. Using lossless compression of the quantizer's output, Gish and Pierce showed that uniform quantizing yields the smallest output entropy in the limit D -> 0, resulting in a rate penalty of 0.255 bits/sample above the Shannon Lower Bound (SLB). We present a scalar quantization scheme named lossy-bit entropy-constrained scalar quantization (Lb-ECSQ) that is able to reduce the D -> 0 gap to SLB to 0.251 bits/sample by combining both lossless and binary lossy compression of the quantizer's output. We also study the low-resolution regime and show that Lb-ECSQ significantly outperforms ECSQ in the case of 1-bit quantization., The authors wish to thank Tobias Koch and Gonzalo Vázquez Vilar for fruitful discussions and helpful comments to the manuscript. This work has been supported in part by the European Union 7th Framework Programme through the Marie Curie Initial Training Network “Machine Learning for Personalized Medicine” MLPM2012, Grant No. 316861, by the Spanish Ministry of Economy and Competitiveness and Ministry of Education under grants TEC2016-78434-C3-3-R (MINECO/FEDER, EU) and IJCI-2014-19150, and by Comunidad de Madrid (project ’CASI-CAM-CM’, id. S2013/ICE-2845)., Publicado
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubuk, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo González, Francesca
  • Herranz, Carmen
  • Carbonell Caballero, José
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation

  • Dopazo, Joaquín
  • Rodríguez-Pérez, Juan Antonio
  • Daub, Josephine T.
  • Muntané, Gerard
  • Ruiz-Ferrer, Macarena
  • Méndez-Vidal, Cristina
  • Bhattacharya, Shom Shanker
  • Borrego, Salud
  • Antiñolo, Guillermo
Dopazo, Joaquín et al., Recent results from large-scale genomic projects suggest that allele frequencies, which are highly relevant for medical purposes, differ considerably across different populations. The need for a detailed catalog of local variability motivated the whole-exome sequencing of 267 unrelated individuals, representative of the healthy Spanish population. Like in other studies, a considerable number of rare variants were found (almost one-third of the described variants). There were also relevant differences in allelic frequencies in polymorphic variants, including ~10,000 polymorphisms private to the Spanish population. The allelic frequencies of variants conferring susceptibility to complex diseases (including cancer, schizophrenia, Alzheimer disease, type 2 diabetes, and other pathologies) were overall similar to those of other populations. However, the trend is the opposite for variants linked to Mendelian and rare diseases (including several retinal degenerative dystrophies and cardiomyopathies) that show marked frequency differences between populations. Interestingly, a correspondence between differences in allelic frequencies and disease prevalence was found, highlighting the relevance of frequency differences in disease risk. These differences are also observed in variants that disrupt known drug binding sites, suggesting an important role for local variability in population-specific drug resistances or adverse effects. We have made the Spanish population variant server web page that contains population frequency information for the complete list of 170,888 variant positions we found publicly available (http://spv.babelomics.org/), We show that it if fundamental to determine population-specific variant frequencies to distinguish real disease associations from population-specific polymorphisms. © 2016 The Author 2016. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution., The MGP is a joint initiative between the Consejería de Salud de la Junta de Andalucía and Roche, supported by the “Programa Nacional de Proyectos de investigación Aplicada,” I+D+i 2008, “Subprograma de actuaciones Científicas y Tecnológicas en Parques Científicos y Tecnológicos” (ACTEPARQ 2009), and European Regional Development Funds (ERDF). This work is also supported by grants BIO2014-57291-R and BFU2012-38236 from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT 13/0001/0030 from the ISCIII, both cofunded with ERDF; grants PI1102923 and PI1001290 from the Fondo de Investigación Sanitaria, PROMETEOII/2014/025 from the Generalitat Valenciana (GVA-FEDER), FP7-PEOPLE-2012-ITN MLPM2012 318861 from the EU FP7, Fundació la Marató TV3 [20133134], and by Direcció General de Recerca, Generalitat de Catalunya (2014SGR1311). The CIBER de Enfermedades Raras is an Instituto de Salud Carlos III initiative., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubuk, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo González, Francesca
  • Herranz, Carmen
  • Carbonell Caballero, José
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions.